The global VNA & PACS market is projected to reach USD 7.92 billion by 2030 from USD 5.10 billion in 2025, at a CAGR of 9.2% during the forecast period. Market expansion is largely fueled by the surging volume of medical imaging data, the transition towards enterprise-wide interoperability, and the increasing demand for centralized, vendor-neutral platforms designed to optimize imaging workflows. Additionally, initiatives aimed at healthcare digitization and regulatory frameworks promoting health information exchange are further catalyzing market growth. However, the high costs associated with implementation and the complexities related to data migration remain significant barriers to the adoption of advanced VNA and PACS, particularly for small to mid-sized healthcare organizations.
As hospitals and health systems consolidate into integrated networks, the establishment of a comprehensive imaging repository has become essential for facilitating seamless data access and collaborative diagnostic efforts. Additionally, the transition towards remote diagnostics, teleconsultations, and virtual care frameworks - exacerbated by the COVID-19 pandemic - has underscored the imperative for scalable, multi-site VNAs that enable secure and anytime-anywhere access to medical imaging. These advanced solutions not only help dismantle data silos and minimize image duplication but also enhance care coordination across various departments and facilities.
A critical consideration in this area is the total cost of ownership (TCO). Although cloud-based solutions typically offer greater agility and require a lower upfront investment, on-premises deployment often provides superior long-term return on investment (ROI), especially for institutions equipped with established IT teams and fixed imaging volume requirements. Furthermore, advancements in hardware efficiencies are making local deployments increasingly economical and dependable.
Concurrently, technological advancements and the increasing adoption of cloud computing are rendering enterprise imaging solutions - specifically VNA and PACS - more scalable and cost-efficient across institutions of varying sizes. As digital health strategies emerge as national imperatives, there is an intensified focus on optimizing imaging workflows, facilitating remote access to radiological data, and promoting cross-facility data interoperability. These objectives are well-aligned with the inherent advantages offered by VNA and PACS platforms, which support integrated and seamless management of imaging information.
On the basis of product type, the multi-site VNA segment is expected to witness the highest growth rate during the forecast period.
Based on product type, the VNA & PACS market is segmented into VNA (further subsegmented into department, multi-department, and multi-site VNA) and PACS (further subsegmented into department, multi-department, and multi-site PACS). The multi-site VNA subsegment is expected to witness the fastest CAGR during the forecast period. The escalating demand for medical imaging solutions is primarily driven by the increasing emphasis of healthcare systems on interoperability and cross-institutional data integration to optimize imaging workflows across diverse geographical locations.As hospitals and health systems consolidate into integrated networks, the establishment of a comprehensive imaging repository has become essential for facilitating seamless data access and collaborative diagnostic efforts. Additionally, the transition towards remote diagnostics, teleconsultations, and virtual care frameworks - exacerbated by the COVID-19 pandemic - has underscored the imperative for scalable, multi-site VNAs that enable secure and anytime-anywhere access to medical imaging. These advanced solutions not only help dismantle data silos and minimize image duplication but also enhance care coordination across various departments and facilities.
On the basis of deployment, the on-premises deployment segment held the largest market share in 2024.
On the basis of deployment, the VNA & PACS market has been segmented into on-premises, cloud-based, and hybrid deployment. The on-premises deployment segment held the largest market share in 2024. Healthcare institutions are increasingly favoring on-premises deployment in infrastructure to maintain oversight and achieve long-term cost predictability, particularly those with substantial resources or large-scale operations. These organizations prioritize security and performance stability, which aligns well with capital budgeting practices. By managing storage internally, they ensure compliance with stringent data governance standards while consistently delivering reliable imaging performance.A critical consideration in this area is the total cost of ownership (TCO). Although cloud-based solutions typically offer greater agility and require a lower upfront investment, on-premises deployment often provides superior long-term return on investment (ROI), especially for institutions equipped with established IT teams and fixed imaging volume requirements. Furthermore, advancements in hardware efficiencies are making local deployments increasingly economical and dependable.
On the basis of region, the Asia Pacific is expected to witness the highest CAGR from 2025 to 2030.
On the basis of region, the VNA & PACS market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Among these, the Asia Pacific market is expected to witness the highest CAGR due to an increased investment in medical imaging infrastructure, expanding healthcare access, and the rapid digitization of hospital systems across emerging economies. Countries such as India, China, and various Southeast Asian nations are enhancing their diagnostic imaging capabilities, leading healthcare organizations to explore centralized and interoperable solutions for the management of clinical images and associated data.Concurrently, technological advancements and the increasing adoption of cloud computing are rendering enterprise imaging solutions - specifically VNA and PACS - more scalable and cost-efficient across institutions of varying sizes. As digital health strategies emerge as national imperatives, there is an intensified focus on optimizing imaging workflows, facilitating remote access to radiological data, and promoting cross-facility data interoperability. These objectives are well-aligned with the inherent advantages offered by VNA and PACS platforms, which support integrated and seamless management of imaging information.
The breakdown of primary participants is as mentioned below:
- By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
- By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
- By Region - North America: 32%, Europe: 30%, Asia Pacific: 25%, Middle East & Africa: 5%, Latin America: 5%
Key Players
The key players functioning in the VNA & PACS market include Hyland Software, Inc. (US), Agfa-Gevaert Group (Belgium), Intelerad Medical Systems Inc. (Canada), Canon Medical Systems Corporation (Japan), FUJIFILM Holdings Corporation (Japan), GE Healthcare (US), Merative (US), Sectra AB (Sweden), Siemens Healthcare Limited (Germany), BridgeHead Software Ltd. (UK), Canopy Partners. (US), Novarad Corporation (US), POSTDICOM (Netherlands), AdvaHealth Solutions Pte Ltd. (Singapore), CrelioHealth (India), Medicasoft (US), Esaote S.p.A. (Italy), PaxeraHealth (US), VISUS Health IT GmbH (Germany), ASPYRA, LLC (US), Dedalus S.p.A. (Italy), SoftTeam Solutions Pvt. Ltd. (India), ARO Systems (Australia), Central Data Networks (Australia), and ONEPACS (US).Research Coverage:
The report analyses the VNA & PACS market to estimate the market size and future growth potential of various market segments based on product type, modality, deployment, vendor type, application, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.Reasons to Buy the Report
This report provides valuable insights for both established firms and emerging or smaller players, enabling them to accurately assess market dynamics. By leveraging the information presented, organizations can adopt various strategies outlined below to enhance their competitive positioning and increase market share.This report provides insights on:
- Analysis of DROCs: Drivers [increasing investments in medical imaging technologies, growing demand for streamlined healthcare data management solutions, Integration of PACS/VNA with electronic medical records (EMRs)], restraints [increasing data security and privacy concerns, high initial investment, lack of standardized protocols and interoperability frameworks], opportunities [government initiatives to increase penetration of Al in medical imaging, Increasing medical imaging procedures and large imaging data silos, rapid uptake of big data in healthcare], and challenges [rising security concerns related to cloud-based image processing and analytics, data security issues] influencing the growth of the VNA & PACS market.
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product & service launches in the VNA & PACS market
- Market Development: Comprehensive information on the lucrative emerging markets, product type, modality, deployment, vendor type, application, end user, and region.
- Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the VNA & PACS market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the VNA & PACS market, such as Agfa-Gevaert Group (Belgium), FUJIFILM Holdings Corporation (Japan), Sectra AB (Sweden), Merative (US), and GE Healthcare (US).
Table of Contents
1 Introduction
2 Research Methodology
4 Premium Insights
5 Market Overview
6 Vna & Pacs Market, by Modality
7 Vna & Pacs Market, by Deployment Model
8 Vna & Pacs Market, by Product Type
9 Vna & Pacs Market, by Vendor Type
10 Vna & Pacs Market, by Application
11 Vna & Pacs Market, by End-user
12 Vna & Pacs Market, by Region
13 Competitive Landscape
14 Company Profiles
15 Appendix
List of Tables
List of Figures
Companies Mentioned
- Agfa-Gevaert Group
- Fujifilm Holdings Corporation
- Sectra Ab
- GE Healthcare
- Merative
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Intelerad. Intelerad.
- Paxerahealth
- Novarad Corporation
- Hyland Software, Inc.
- Siemens Healthineers AG
- Bridgehead Software Ltd.
- Canopy Partners
- Creliohealth Inc.
- Aspyra, LLC
- Postdicom
- Medicasoft
- Esaote S.P.A.
- Visus Health IT GmbH
- Advahealth Solutions
- Softteam Solutions Pvt. Ltd.
- Aro Systems
- Central Data Networks
- Onepacs
- Dedalus S.P.A.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 289 |
| Published | May 2025 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value ( USD | $ 5.1 Billion |
| Forecasted Market Value ( USD | $ 7.92 Billion |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
